Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young

New England Journal of Medicine

Volumn 345, Issue 13, 2001, Pages 971-980

  Fajans, Stefan S ^a,d   Bell, Graeme I ^b   Polonsky, Kenneth S ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; INSULIN PROMOTER FACTOR 1; NEUROGENIC DIFFERENTIATION FACTOR; ORAL ANTIDIABETIC AGENT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESPONSE; MATURITY ONSET DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 2; GENETIC SCREENING; GLUCOKINASE; GLUCOSE; HUMANS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; MUTATION; TRANSCRIPTION FACTORS;

EID: 0035960122     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra002168     Document Type: Review

References (68)

1. Hyperexcitability to sulphonylurea in MODY3
2. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: Evidence for pharmacogenetics in diabetes
3. Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus
4. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
5. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
6. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
7. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY
8. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
9. MODY: A model for understanding the pathogeneses and natural history of type II diabetes
10. Scope and heterogeneous nature of MODY
11. Maturity-onset diabetes of the young
12. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young
13. Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the U.K.
14. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed?
15. MODY a model for the study of the molecular genetics of NIDDM
16. Pancreatic β-cell glucokinase: Closing the gap between theoretical concepts and experimental realities
17. Neonatal diabetes mellitus due to complete glucokinase deficiency
18. Liver-enriched transcription factors and hepatocyte differentiation
19. Regulation of a transcription factor network required for differentiation and metabolism
20. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism
21. Hepatocyte nuclear factor 4α regulates the expression of pancreatic β-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion
22. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3
23. Pancreas development and diabetes
24. Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells
25. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice
26. Glucokinase
27. β-cell genes and diabetes: Quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations
28. MODY2 presenting as neonatal hyperglycaemia: A need to reshape the definition of "neonatal diabetes"?
29. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
30. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q
31. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
32. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
33. Mutations in the glucokinase gene of the fetus result in reduced birth weight
34. The β-cell in diabetes: From molecular genetics to clinical research
35. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations
36. Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice
37. Maturity-onset diabetes of the young: A model for genetic studies of diabetes mellitus
38. Chronic diabetic complications in patients with MODY3 diabetes
39. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young
40. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree
41. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20
42. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
43. Characterization of the MODY3 phenotype: Early-onset diabetes caused by an insulin secretion defect
44. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4α/MODY1 gene
45. Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: Clinical features and functional characterization
46. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4α/MODY1 gene
47. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice
48. Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice
49. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene
50. HNF1α controls renal glucose reabsorption in mouse and man
51. Genotype/phenotype relationships in HNF-4α/MODY1: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
52. Mutation in the HNF-4α gene affects insulin secretion and triglyceride metabolism
53. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis
54. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene)
55. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1β gene associated with diabetes and renal dysfunction
56. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β
57. Splice site mutation in the hepatocyte nuclear factor-1β gene, IVS2nt+1G>A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterus
58. Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease
59. Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history
60. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
61. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
62. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and lateonset NIDDM
63. A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus
64. The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree
65. Natural history, genetics and pathogenesis of HNF-4α/MODY1: A 40-year prospective study of the KW pedigree
66. Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM
67. Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having type I diabetes
68. A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea